Author: admin

Integral Molecular Secures $8 Million NIAID Contract to Combat Emerging Viruses

Philadelphia– Integral Molecular, a leader in developing advanced technologies for the discovery of vaccines and therapeutics, is excited to announce a five-year, $8 million […]

Up to One-Third of Antibody Drugs Are Nonspecific, Study Shows

Integral Molecular’s Membrane Proteome Array™ Reveals Pervasive Binding of Antibody-Based Drugs to Unintended Targets Philadelphia– Integral Molecular, a leader in antibody discovery and characterization, […]

Integral Molecular Achieves ISO 9001 Certification for its Virology Critical Reagents Supporting Vaccine Development

Philadelphia– Integral Molecular, a leader in providing essential research tools that enable vaccine development, proudly announces the achievement of ISO 9001 certification for the […]

Antibody Startup Emerges from Stealth: Cell Surface Bio Set to Transform the $10B Antibody Reagent Market

Company debuts catalog of validated, recombinant, specific antibodies against difficult protein targets, providing only the highest quality reagents for life sciences research Philadelphia – […]

Webinar Presented by Integral Molecular and Fierce Biotech – Redefining Antibody Specificity Profiling for IND

Thursday, June 6, 2024 8 am PT, 11 am ET, 17:00 CET View the recording Assessment of antibody off-target reactivity is a regulatory requirement […]

Integral Molecular Launches Virus Neutralization Assay Services to Drive Antiviral Discovery

Researchers can now access Integral Molecular’s antibody testing expertise alongside its extensive collection of virus-like reagents including reporter viruses, VLPs, and pseudoviruses to acquire […]

Webinar Presented by Integral Molecular and The Antibody Society – Harnessing Divergent Species to Access Difficult and Conserved Antibody Targets

Thursday, April 25, 2024 8 am PT, 11 am ET, 17:00 CET View the recording To exploit highly conserved and difficult drug targets, including […]

Integral Molecular Achieves ISO 9001 Certification for its Membrane Proteome Array Service

ISO 9001 certification validates Integral Molecular’s quality processes for its Membrane Proteome Array, reflecting the company’s commitment to quality. Philadelphia – Integral Molecular, a […]

Integral Molecular Enters Into Exclusive Antibody License With Seismic Therapeutic

Philadelphia – Integral Molecular, a leading biotech company specializing in antibody discovery against undruggable protein targets, announced today that it has entered into an […]